ÂÜÀòÂÒÂ×

Glenn Whaley is the Vice President of Finance and Principal Financial and Accounting Officer at Immunic Therapeutics. Glenn has been in this role since August 2019. Prior to that, they were the VP Finance, Principal Accounting Officer and Controller at Pernix Therapeutics from April 2015 to August 2019. During their time at Pernix, they were a member of the company's Executive Leadership Team and was responsible for all financial operations, including monthly close, SEC financial reporting, monthly financial analysis and reporting, 5 year planning, annual budgeting cycles, rolling monthly forecasts, quarterly financial press releases and earnings call talking points, monthly/quarterly lender reporting, operational KPI tracking, gross to net accounting, stock option/RSU administration and accounting, pricing committee, sales territory profitability analysis, weekly cash forecast, accounts payable, tax, payroll, and technical accounting. Glenn was also the financial representative for reviewing external collaborations and the cross functional liaison for all financial matters.

From May 2011 to March 2015, Glenn was the VP Corporate Controller at Alvogen. In this role, they advised executive management regarding technical accounting, auditing and financial reporting issues.

Glenn Whaley earned their BS in Accounting from Rutgers University and is certified by the NJ state society of Accountants as a Certified Public Accountant (CPA).